StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$4.24−0.29 (-6.40%)

Close on Nov 16, 2026Market cap $4.24MP/E –Yield –

Shuttle Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$11.63M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.63M–
FY2024Dec 31, 2024-$7.69M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.32M–
Q1 FY2026Mar 31, 2026-$1.58M–
Q2 FY2025Jun 30, 2025-$3.91M–
Q1 FY2025Mar 31, 2025-$2.95M–

More Shuttle Pharmaceuticals figures

See a number that looks wrong?